Viewing StudyNCT00410358



Ignite Creation Date: 2024-05-05 @ 5:15 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00410358
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2006-12-11

Brief Title: A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Tumors
Keywords:
Name View
advanced solid tumors View
Gimatecan View
topoisomerase I inhibitor View